Home/Filings/4/0001415889-24-027567
4//SEC Filing

Grimaud Brett A. 4

Accession 0001415889-24-027567

CIK 0001583107other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 6:06 PM ET

Size

4.9 KB

Accession

0001415889-24-027567

Insider Transaction Report

Form 4
Period: 2024-11-20
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
Transactions
  • Tax Payment

    Ordinary Shares

    2024-11-20$9.97/sh9,268$92,402333,345 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001966698

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:06 PM ET
Size
4.9 KB